Search Tag: prostate cancer
2024 09 Dec
<marquee behavior="slide" direction="left" scrollamount="30"> <h2 style="text-align: center;"><font color="#000099"><b>Find ESMO On Social Media</b> </font></h2><div style="text-align: center;"><a href=https://www.twitter.com/myesmo target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65></a><Read more
2024 18 Dec
<marquee behavior="slide" direction="left" scrollamount="30"> <h2 style="text-align: center;"><font color="#000099"><b>Find ESMO On Social Media</b> </font></h2><div style="text-align: center;"><a href=https://www.twitter.com/myesmo target="_blank"><img src="/uploads/twnew.png" style="text-align: initial;" width=65 height=65></a><Read more
2021 08 Oct
Executive Summary Cancer care is becoming increasingly complex and personalized. More and more patient characteristics and disease specific data – clinical history, comorbidities, imaging, laboratory data, genomics/ proteomics, lifestyle factors, pathology results – have to be factored in when deciding on diagnostic measures and care pathways....Read more
2020 21 Apr
A research predicts a decline in cancer mortality rates in 2020 in the EU. However, due to the COVID-19 pandemic cancer patient safety is compromised, but can still be improved with certain policies. You may also like : Prostate is Now Most Common Cancer Cancer in the EU Total cancer mortality rates in the...Read more
2020 29 Jan
Prostate cancer is now the most commonly diagnosed cancer in England. According to the data revealed by Public Health England (PHE), in 2018 (latest data available), it overtook breast cancer for the first time. You may also like: RSNA 2019: Novel MRI-Guided Ultrasound Treatment Destroys Prostate Cancer This is attributed...Read more
2016 29 Apr
Urologists at University of California San Diego School of Medicine and Genesis Healthcare Partners have tested a new model of care for patients with low-risk prostate cancer. The evidence-based approach uses best practices to appropriately select and follow patients to avoid disease overtreatment. Results of the three-year study are now published...Read more
2014 10 Dec
The first study of its kind by UCLA researchers has found that despite the fact that more than half of prostate cancer patients 66 years of age and older have life expectancies of less than ten years, half of them are over-treated for prostate cancer with surgery, radiation or brachytherapy. National guidelines recommend that men with life expectancy of...Read more